Systematic Review of the Cost Effectiveness of Dapagliflozin Used to Treat Patients with Type 2 Diabetes Mellitus
Document Type
Presentation
Publication Date
5-21-2018
Recommended Citation
Loh, F. E., Tsan, J. Duong, T., Girgis, N., Labib, M., & Moustakas, A. (2018, May 21). Systematic review of the cost effectiveness of Dapagliflozin used to treat patients with type 2 diabetes mellitus. Presentation at the ISPOR 23rd Annual International Meeting, Baltimore, Maryland.
COinS
